Congratulations to our Regulatory team on obtaining the Marketing Authorisation for our Fampridine 10 mg prolonged release tablets in Germany. Thank you to everyone involved for the outstanding work.

Please contact us at info@intasb2b.com for more information.
To view region specific filing plan and available MAs, click the relevant link below.

www.intasportfolio.com

Published on February 9, 2021